Log In
Print
BCIQ
Print
Print this Print this
 

Rebif, interferon beta-1a

  Manage Alerts
Collapse Summary General Information
Company Merck KGaA
DescriptionRecombinant interferon (IFN) beta-1a
Molecular Target Type I interferon (IFN) receptor
Mechanism of ActionType I interferon (IFN) receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS); Treat relapsing multiple sclerosis (MS); Treat relapsing-remitting multiple sclerosis (RRMS); Treat secondary progressive multiple sclerosis (SPMS)
Regulatory Designation

Partner

Pfizer Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today